• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为了在避免冷链的情况下保持纳米颗粒携带的蛋白质抗原的免疫原性。

Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, United States.

出版信息

Int J Pharm. 2010 Jun 30;393(1-2):197-202. doi: 10.1016/j.ijpharm.2010.04.003. Epub 2010 Apr 21.

DOI:10.1016/j.ijpharm.2010.04.003
PMID:20416366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2893573/
Abstract

Nanoparticles are an attractive vaccine carrier with potent adjuvant activity. Data from our previous studies showed that immunization of mice with lecithin/glyceryl monostearate-based nanoparticles with protein antigens conjugated onto their surface induced a strong, quick, and long-lasting antigen-specific immune response. In the present study, we evaluated the feasibility of preserving the immunogenicity of protein antigens carried by nanoparticles without refrigeration using these antigen-conjugated nanoparticles as a model. The nanoparticles were lyophilized, and the immunogenicity of the antigens was evaluated in a mouse model using bovine serum albumin or the Bacillus anthracis protective antigen protein as model antigens. With proper excipients, the nanoparticles can be lyophilized while maintaining the immunogenicity of the antigens. Moreover, the immunogenicity of the model antigen conjugated onto the nanoparticles was undamaged after a relatively extended period of storage at room temperature or under accelerated conditions (37 degrees C) when the nanoparticles were lyophilized with 5% mannitol plus 1% polyvinylpyrrolidone. To our knowledge, the present study represents an early attempt to preserve the immunogenicity of the protein antigens carried by nanoparticles without refrigeration.

摘要

纳米颗粒是一种有吸引力的疫苗载体,具有很强的佐剂活性。我们之前的研究数据表明,用表面连接有蛋白抗原的卵磷脂/甘油单硬脂酸酯纳米颗粒免疫小鼠,可诱导强烈、快速和持久的抗原特异性免疫应答。在本研究中,我们评估了使用这些抗原偶联纳米颗粒作为模型,在不冷藏的情况下保持纳米颗粒携带的蛋白抗原免疫原性的可行性。将纳米颗粒冷冻干燥,并在小鼠模型中使用牛血清白蛋白或炭疽保护性抗原蛋白作为模型抗原来评估抗原的免疫原性。通过适当的赋形剂,纳米颗粒可以在冷冻干燥的同时保持抗原的免疫原性。此外,当纳米颗粒用 5%甘露醇加 1%聚乙烯吡咯烷酮冷冻干燥时,在室温或加速条件(37 摄氏度)下储存相对较长时间后,模型抗原在纳米颗粒上的免疫原性并未受损。据我们所知,本研究代表了早期尝试在不冷藏的情况下保持纳米颗粒携带的蛋白抗原免疫原性的努力。

相似文献

1
Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain.为了在避免冷链的情况下保持纳米颗粒携带的蛋白质抗原的免疫原性。
Int J Pharm. 2010 Jun 30;393(1-2):197-202. doi: 10.1016/j.ijpharm.2010.04.003. Epub 2010 Apr 21.
2
Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles.基于卵磷脂的纳米粒子表面连接的蛋白抗原诱导强烈的抗体应答。
J Control Release. 2010 Jan 4;141(1):93-100. doi: 10.1016/j.jconrel.2009.08.023. Epub 2009 Sep 1.
3
Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.新型佐剂鼻用疫苗的研发:与壳聚糖纳米颗粒结合的C48/80作为增强黏膜免疫的途径
Eur J Pharm Biopharm. 2015 Jun;93:149-64. doi: 10.1016/j.ejpb.2015.03.024. Epub 2015 Mar 26.
4
Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine.生物物理特性分析及免疫研究:优势阴性抑制剂(DNI),炭疽毒素亚单位候选疫苗。
Hum Vaccin Immunother. 2013 Nov;9(11):2362-70. doi: 10.4161/hv.25852. Epub 2013 Aug 7.
5
Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.吸附于氢氧化铝佐剂的炭疽重组保护性抗原的结构与免疫学分析
Clin Vaccine Immunol. 2012 Sep;19(9):1465-73. doi: 10.1128/CVI.00174-12. Epub 2012 Jul 18.
6
Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.用双抗原炭疽疫苗进行鼻腔免疫可诱导针对毒素和杆菌的强烈黏膜及全身免疫反应。
Vaccine. 2006 Sep 29;24(40-41):6405-13. doi: 10.1016/j.vaccine.2006.06.002. Epub 2006 Jun 19.
7
A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.一种单剂量 PLGA 包封保护性抗原结构域 4 纳米制剂可保护小鼠免受炭疽芽孢杆菌孢子的攻击。
PLoS One. 2013 Apr 29;8(4):e61885. doi: 10.1371/journal.pone.0061885. Print 2013.
8
Ability of ELISA and a toxin neutralization assay to detect changes in immunogenicity of a recombinant Bacillus anthracis protective antigen vaccine upon storage.酶联免疫吸附测定(ELISA)和毒素中和试验检测重组炭疽芽孢杆菌保护性抗原疫苗储存后免疫原性变化的能力。
Biologicals. 2013 Mar;41(2):111-4. doi: 10.1016/j.biologicals.2012.10.002. Epub 2012 Nov 6.
9
Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice.毛细血管形态发生蛋白 2 的 von Willebrand 因子 A 结构域与炭疽保护性抗原疫苗结合可降低小鼠的免疫原性。
mSphere. 2020 Jan 15;5(1):e00556-19. doi: 10.1128/mSphere.00556-19.
10
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.用新型纳米乳剂重组炭疽保护性抗原疫苗进行黏膜免疫可抵御炭疽芽孢杆菌孢子攻击。
Infect Immun. 2007 Aug;75(8):4020-9. doi: 10.1128/IAI.00070-07. Epub 2007 May 14.

引用本文的文献

1
Development of thermostable vaccine adjuvants.耐热疫苗佐剂的开发。
Expert Rev Vaccines. 2021 May;20(5):497-517. doi: 10.1080/14760584.2021.1902314. Epub 2021 Jun 26.
2
Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant.壳聚糖加复合48/80:作为乙肝疫苗佐剂的配方及初步评价。
Pharmaceutics. 2019 Feb 9;11(2):72. doi: 10.3390/pharmaceutics11020072.
3
Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles.使用聚乳酸-羟基乙酸共聚物纳米颗粒携带的质粒诱导针对C型肉毒杆菌神经毒素的保护性中和抗体反应。
Hum Vaccin Immunother. 2016 May 3;12(5):1188-92. doi: 10.1080/21645515.2015.1122147. Epub 2016 Feb 2.
4
A polymer/oil based nanovaccine as a single-dose immunization approach.聚合物/油基纳米疫苗作为一种单剂量免疫接种方法。
PLoS One. 2013 Apr 22;8(4):e62500. doi: 10.1371/journal.pone.0062500. Print 2013.
5
Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles.微针介导经皮免疫用阳离子 PLGA 纳米粒包被的质粒 DNA
J Control Release. 2012 Oct 28;163(2):230-9. doi: 10.1016/j.jconrel.2012.08.011. Epub 2012 Aug 19.
6
Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.抗原蛋白偶联纳米颗粒和活菌经微针处理后的小鼠皮肤渗透。
Int J Nanomedicine. 2011;6:1253-64. doi: 10.2147/IJN.S20413. Epub 2011 Jun 21.
7
Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design.纳米颗粒大小与其佐剂活性之间的关系:一项采用改进实验设计的研究数据。
Eur J Pharm Biopharm. 2011 May;78(1):107-16. doi: 10.1016/j.ejpb.2010.12.017. Epub 2010 Dec 21.
8
Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity.基于三嗪的蛋白抗原与脂质纳米颗粒的连接可提高抗原的免疫原性。
Int J Pharm. 2010 Nov 30;401(1-2):87-92. doi: 10.1016/j.ijpharm.2010.09.003. Epub 2010 Sep 15.
9
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.纳米-微米颗粒作为免疫佐剂:相关的颗粒大小和产生的免疫反应。
Expert Rev Vaccines. 2010 Sep;9(9):1095-107. doi: 10.1586/erv.10.89.

本文引用的文献

1
Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles.基于卵磷脂的纳米粒子表面连接的蛋白抗原诱导强烈的抗体应答。
J Control Release. 2010 Jan 4;141(1):93-100. doi: 10.1016/j.jconrel.2009.08.023. Epub 2009 Sep 1.
2
Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel.由水包卵磷脂乳液制备的纳米颗粒作为多西他赛的潜在递送系统。
Int J Pharm. 2009 Sep 8;379(1):174-80. doi: 10.1016/j.ijpharm.2009.06.004. Epub 2009 Jun 11.
3
Opportunities and challenges of developing thermostable vaccines.开发耐热疫苗的机遇与挑战。
Expert Rev Vaccines. 2009 May;8(5):547-57. doi: 10.1586/erv.09.20.
4
Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.疫苗佐剂系统:增强亚单位蛋白抗原的功效
Int J Pharm. 2008 Dec 8;364(2):272-80. doi: 10.1016/j.ijpharm.2008.04.036. Epub 2008 Apr 30.
5
Development of stable influenza vaccine powder formulations: challenges and possibilities.稳定流感疫苗粉末制剂的研发:挑战与可能性
Pharm Res. 2008 Jun;25(6):1256-73. doi: 10.1007/s11095-008-9559-6.
6
Nanoparticles and microparticles as vaccine-delivery systems.作为疫苗递送系统的纳米颗粒和微粒
Expert Rev Vaccines. 2007 Oct;6(5):797-808. doi: 10.1586/14760584.6.5.797.
7
Anthrax toxin: receptor binding, internalization, pore formation, and translocation.炭疽毒素:受体结合、内化、孔形成及转位
Annu Rev Biochem. 2007;76:243-65. doi: 10.1146/annurev.biochem.75.103004.142728.
8
Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.用双抗原炭疽疫苗进行鼻腔免疫可诱导针对毒素和杆菌的强烈黏膜及全身免疫反应。
Vaccine. 2006 Sep 29;24(40-41):6405-13. doi: 10.1016/j.vaccine.2006.06.002. Epub 2006 Jun 19.
9
Lecithin-based cationic nanoparticles as a potential DNA delivery system.
Int J Pharm. 2006 Apr 26;313(1-2):206-13. doi: 10.1016/j.ijpharm.2006.01.042. Epub 2006 Feb 23.
10
Recombinant subunit vaccines: potentials and constraints.重组亚单位疫苗:潜力与局限
Dev Biol (Basel). 2005;121:153-63.